Daily Light and Sound Stimulation to Improve Brain Functions in Alzheimer's Disease
NCT: NCT04055376 · ACTIVE_NOT_RECRUITING
Brief Summary
In this trial, the safety and effect of daily exposure to light and sound stimulation on people with mild Alzheimer's Disease (AD) will be studied. COVID-19 Amendment: Due to the ongoing suspension of all in-person humans subject research across MIT in response to the COVID-19 pandemic, all enrolled participants who have not completed their 6-month visit will have their visit postponed to 9 months with a follow up at 18 months. Subjects who have completed their 6-month visit will still be instructed to continue and return at Month 12 for an evaluation. OPTIONAL: If the subject would like to come in for an evaluation between Month 9 and 18, we will invite participants to come on Month 12 to complete cognitive testing and EEG.
Frequently Asked Questions
What is Daily Light and Sound Stimulation to Improve Brain Functions in Alzheimer's Disease?
Daily Light and Sound Stimulation to Improve Brain Functions in Alzheimer's Disease is a clinical trial registered under NCT04055376. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT04055376?
The current status of NCT04055376 (Daily Light and Sound Stimulation to Improve Brain Functions in Alzheimer's Disease) is: ACTIVE_NOT_RECRUITING.
When did Daily Light and Sound Stimulation to Improve Brain Functions in Alzheimer's Disease start?
Daily Light and Sound Stimulation to Improve Brain Functions in Alzheimer's Disease started on 2019-08-14.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.